Home Tech Ecosystemfundings DTx Pharma Raises $100 Million in Series B

DTx Pharma Raises $100 Million in Series B

by FBT Team

San Diego-based DTx Pharma, a biotechnology company that uses RNA-based therapies to treat genetic factors of genetic diseases, raised $100 Million in a Series B round. 

Their platform, FALCON (Fatty Acid Ligand Conjugated Oligonucleotide), allows the team to look into diseases in skeletal muscle, cardiac muscle, and the peripheral nervous system. 

Read more about the funding here

 

Related Articles

Leave a Comment

Stay ConnectedStay in the loop on all things tech in sunny San Diego with our biweekly newsletters.

Stay up to date on the latest insights into San Diego's tech community! Highlighting local leaders, connecting the great community and being your "one-stop" for all things technology.

Stay ConnectedStay in the loop on all things tech in sunny San Diego with our biweekly newsletters.

Stay up to date on the latest insights into San Diego's tech community! Highlighting local leaders, connecting the great community and being your "one-stop" for all things technology.